MARRONE BIO INNOVATIONS INC. Operating Cash Flow
MARRONE BIO INNOVATIONS INC. reported Operating Cash Flow of -$8.40 million for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2022-05-13
- MARRONE BIO INNOVATIONS INC. net cash provided by (used in) operating activities for the quarter ending 2022-03-31 was -$8.40M.
- MARRONE BIO INNOVATIONS INC. net cash provided by (used in) operating activities for the quarter ending 2021-12-31 was -$3.39M.
- MARRONE BIO INNOVATIONS INC. net cash provided by (used in) operating activities for the quarter ending 2021-09-30 was -$308.00K.
- MARRONE BIO INNOVATIONS INC. net cash provided by (used in) operating activities for the quarter ending 2021-06-30 was -$1.25M.
- MARRONE BIO INNOVATIONS INC. net cash provided by (used in) operating activities for fiscal 2021 was -$9.96M.
- MARRONE BIO INNOVATIONS INC. net cash provided by (used in) operating activities for fiscal 2020 was -$15.96M.
- MARRONE BIO INNOVATIONS INC. net cash provided by (used in) operating activities for fiscal 2019 was -$21.34M.
- MARRONE BIO INNOVATIONS INC. net cash provided by (used in) operating activities for fiscal 2018 was -$19.43M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$8.40M 10-Q · filed 2022-05-13 | -$11.79M derived: sum of 2 quarters · filed 2022-05-13 | -$12.09M derived: sum of 3 quarters · filed 2022-05-13 | -$13.34M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-12-31 | -$3.39M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-05-09 | -$3.70M derived: sum of 2 quarters · filed 2022-05-09 | -$4.94M derived: sum of 3 quarters · filed 2022-05-09 | -$9.96M 10-K/A · filed 2022-05-09 |
| 2021-09-30 | -$308.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$1.55M derived: sum of 2 quarters · filed 2021-11-10 | -$6.57M 10-Q · filed 2021-11-10 | -$13.93M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-06-30 | -$1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$6.26M 10-Q · filed 2021-08-16 | -$13.62M derived: sum of 3 quarters · filed 2022-05-13 | -$14.48M derived: sum of 4 quarters · filed 2022-05-13 |
| 2021-03-31 | -$5.02M 10-Q · filed 2022-05-13 | -$12.38M derived: sum of 2 quarters · filed 2022-05-13 | -$13.23M derived: sum of 3 quarters · filed 2022-05-13 | -$14.68M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | -$7.36M derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-05-09 | -$8.22M derived: sum of 2 quarters · filed 2022-05-09 | -$9.67M derived: sum of 3 quarters · filed 2022-05-09 | -$15.96M 10-K/A · filed 2022-05-09 |
| 2020-09-30 | -$858.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$2.31M derived: sum of 2 quarters · filed 2021-11-10 | -$8.60M 10-Q · filed 2021-11-10 | -$13.54M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | -$1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | -$7.74M 10-Q · filed 2021-08-16 | -$12.69M derived: sum of 3 quarters · filed 2021-08-16 | -$18.43M derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | -$6.29M 10-Q · filed 2021-05-13 | -$11.24M derived: sum of 2 quarters · filed 2021-05-13 | -$16.98M derived: sum of 3 quarters · filed 2021-05-13 | -$19.98M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | -$4.94M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-23 | -$10.69M derived: sum of 2 quarters · filed 2021-03-23 | -$13.69M derived: sum of 3 quarters · filed 2021-03-23 | -$21.34M 10-K · filed 2021-03-23 |
| 2019-09-30 | -$5.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$8.74M derived: sum of 2 quarters · filed 2020-11-09 | -$16.39M 10-Q · filed 2020-11-09 | -$19.01M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | -$3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$10.65M 10-Q · filed 2020-08-10 | -$13.26M derived: sum of 3 quarters · filed 2020-08-10 | -$15.12M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | -$7.65M 10-Q · filed 2020-05-11 | -$10.26M derived: sum of 2 quarters · filed 2020-05-11 | -$12.13M derived: sum of 3 quarters · filed 2020-05-11 | -$17.33M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | -$2.61M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | -$4.47M derived: sum of 2 quarters · filed 2020-03-16 | -$9.68M derived: sum of 3 quarters · filed 2020-03-16 | -$19.43M 10-K · filed 2020-03-16 |
| 2018-09-30 | -$1.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-19 | -$7.07M derived: sum of 2 quarters · filed 2019-11-19 | -$16.81M 10-Q · filed 2019-11-19 | -$23.43M derived: sum of 4 quarters · filed 2019-11-19 |
| 2018-06-30 | -$5.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$14.95M 10-Q · filed 2019-08-09 | -$21.57M derived: sum of 3 quarters · filed 2019-08-09 | -$26.18M derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | -$9.75M 10-Q · filed 2019-05-10 | -$16.36M derived: sum of 2 quarters · filed 2019-05-10 | -$20.97M derived: sum of 3 quarters · filed 2019-05-10 | |
| 2017-12-31 | -$6.62M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | -$11.22M derived: sum of 2 quarters · filed 2019-03-29 | -$21.06M 10-K · filed 2019-03-29 | |
| 2017-09-30 | -$4.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$14.44M 10-Q · filed 2018-11-14 | ||
| 2017-06-30 | -$9.83M 10-Q · filed 2018-08-14 | |||
| 2014-03-31 | -$9.88M 10-Q · filed 2014-05-15 | -$23.47M derived: sum of 2 quarters · filed 2014-05-15 | -$29.48M derived: sum of 3 quarters · filed 2014-05-15 | -$36.21M derived: sum of 4 quarters · filed 2014-05-15 |
| 2013-12-31 | -$13.59M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-25 | -$19.60M derived: sum of 2 quarters · filed 2014-03-25 | -$26.33M derived: sum of 3 quarters · filed 2014-03-25 | -$34.01M 10-K · filed 2014-03-25 |
| 2013-09-30 | -$6.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$12.74M derived: sum of 2 quarters · filed 2013-11-08 | -$20.42M 10-Q · filed 2013-11-08 | -$27.51M derived: sum of 4 quarters · filed 2014-05-15 |
| 2013-06-30 | -$6.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-09-13 | -$14.41M 10-Q · filed 2013-09-13 | -$21.50M derived: sum of 3 quarters · filed 2014-05-15 | -$27.61M derived: sum of 4 quarters · filed 2014-05-15 |
| 2013-03-31 | -$7.67M 10-Q · filed 2014-05-15 | -$14.77M derived: sum of 2 quarters · filed 2014-05-15 | -$20.88M derived: sum of 3 quarters · filed 2014-05-15 | |
| 2012-12-31 | -$7.09M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-25 | -$13.20M derived: sum of 2 quarters · filed 2014-03-25 | -$22.43M 10-K · filed 2014-03-25 | |
| 2012-09-30 | -$6.11M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-08 | -$15.33M 10-Q · filed 2013-11-08 | ||
| 2012-06-30 | -$9.22M 10-Q · filed 2013-09-13 | |||
| 2011-12-31 | -$12.43M 10-K · filed 2014-03-25 |